Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Clifford

Showing results (261-270 of 337) with videos related to

Pageof 34
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2009
Inhibition of poly(ADP-ribose) polymerase-1 enhances temozolomide and topotecan activity against childhood neuroblastomaRachel A Daniel, Agata L Rozanska, Huw D Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
Rapid diagnosis of medulloblastoma molecular subgroupsEd C Schwalbe, Janet C Lindsey, Debbie Straughton, et al.
Neuro-Oncology|October 8, 2024
Molecular and clinical heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcomes: A multicenter cohort studyEdward C Schwalbe, Janet C Lindsey, Marina Danilenko, et al.
Acta Neuropathologica|January 27, 2011
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroupsDavid W Ellison, James Dalton, Mehmet Kocak, et al.
Genes & Development|October 4, 2017
TAp73 is a marker of glutamine addiction in medulloblastomaMaria Victoria Niklison-Chirou, Ida Erngren, Mikael Engskog, et al.
Acta Neuropathologica|July 13, 2022
Single-cell DNA sequencing identifies risk-associated clonal complexity and evolutionary trajectories in childhood medulloblastoma developmentMarina Danilenko, Masood Zaka, Claire Keeling, et al.
Nature Communications|April 13, 2021
Inositol treatment inhibits medulloblastoma through suppression of epigenetic-driven metabolic adaptationSara Badodi, Nicola Pomella, Xinyu Zhang, et al.
Physical Review. E|August 1, 2025
Characterization of electrostatic discharge currents in electron-charged polymethyl methacrylate as a proxy for natural compact intracloud dischargesKathryn M Sturge, Noah Hoppis, Brian L Beaudoin, et al.
Neuropathology and Applied Neurobiology|April 7, 2021
Advanced molecular pathology for rare tumours: A national feasibility study and model for centralised medulloblastoma diagnosticsStephen Crosier, Debbie Hicks, Edward C Schwalbe, et al.
The Lancet. Child & Adolescent Health|November 23, 2020
Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort studyRebecca M Hill, Stacey Richardson, Edward C Schwalbe, et al.
Pageof 34

Showing results (261-270 of 337) with videos related to

Sort By:
Pageof 34
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2009
Inhibition of poly(ADP-ribose) polymerase-1 enhances temozolomide and topotecan activity against childhood neuroblastomaRachel A Daniel, Agata L Rozanska, Huw D Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
Rapid diagnosis of medulloblastoma molecular subgroupsEd C Schwalbe, Janet C Lindsey, Debbie Straughton, et al.
Neuro-Oncology|October 8, 2024
Molecular and clinical heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcomes: A multicenter cohort studyEdward C Schwalbe, Janet C Lindsey, Marina Danilenko, et al.
Acta Neuropathologica|January 27, 2011
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroupsDavid W Ellison, James Dalton, Mehmet Kocak, et al.
Genes & Development|October 4, 2017
TAp73 is a marker of glutamine addiction in medulloblastomaMaria Victoria Niklison-Chirou, Ida Erngren, Mikael Engskog, et al.
Acta Neuropathologica|July 13, 2022
Single-cell DNA sequencing identifies risk-associated clonal complexity and evolutionary trajectories in childhood medulloblastoma developmentMarina Danilenko, Masood Zaka, Claire Keeling, et al.
Nature Communications|April 13, 2021
Inositol treatment inhibits medulloblastoma through suppression of epigenetic-driven metabolic adaptationSara Badodi, Nicola Pomella, Xinyu Zhang, et al.
Physical Review. E|August 1, 2025
Characterization of electrostatic discharge currents in electron-charged polymethyl methacrylate as a proxy for natural compact intracloud dischargesKathryn M Sturge, Noah Hoppis, Brian L Beaudoin, et al.
Neuropathology and Applied Neurobiology|April 7, 2021
Advanced molecular pathology for rare tumours: A national feasibility study and model for centralised medulloblastoma diagnosticsStephen Crosier, Debbie Hicks, Edward C Schwalbe, et al.
The Lancet. Child & Adolescent Health|November 23, 2020
Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort studyRebecca M Hill, Stacey Richardson, Edward C Schwalbe, et al.
Pageof 34